See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2023_BIOMARIN_PHARMACEUTICAL_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001048477, BIOMARIN PHARMACEUTICAL INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,751,457,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 534,768,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,073,366,000 |
| 3 | remainder_Assets | 2,015,483,000 |
| 4 | LiabilitiesCurrent | 588,884,000 |
| 5 | LiabilitiesNoncurrent | 100,015,000 |
| 6 | remainder_Liabilities | 1,083,019,000 |
| 7 | CostOfGoodsAndServicesSold | 483,669,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 854,009,000 |
| 9 | ResearchAndDevelopmentExpense | 649,606,000 |
| 10 | remainder_Expenses | -16,822,000 |
| 11 | remainder_Revenues | 2,096,039,000 |
| 12 | remainder_NetIncome | 15,984,000 |
| 13 | remainder_ComprehensiveNetIncome | -18,299,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,375,074,000 |
| 1 | Liabilities | 1,771,918,000 |
| 2 | Expenses | 1,970,462,000 |
| 3 | Revenues | 2,096,039,000 |
| 4 | StockholdersEquity | 4,603,156,000 |
| 5 | NetIncome | 141,561,000 |
| 6 | ComprehensiveNetIncome | 132,411,500 |
| 7 | BaseVar | 6,123,888,000 |
| 8 | EconomicCapitalRatio | 1.98 |
Edgar->Model Mapping
Feature Distribution
Change over Time
